IA
ONCE

IFP Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

IFP Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-825
Closed -$32K – 3811
2018
Q4 		$32K Sell
825
-50
-6% -$2.17K ﹤0.01% 1876
2018
Q3 		$48K Sell
875
-447
-34% -$30.6K ﹤0.01% 1922
2018
Q2 		$109K Buy
1,322
+770
+139% +$59.4K ﹤0.01% 1432
2018
Q1 		$28K Hold
552
– – ﹤0.01% 2193
2017
Q4 		$28K Sell
552
-1,600
-74% -$115K ﹤0.01% 2221
2017
Q3 		$192K Buy
2,152
+1,785
+486% +$136K 0.01% 1173
2017
Q2 		$22K Sell
367
-458
-56% -$25.6K ﹤0.01% 2540
2017
Q1 		$44K Sell
825
-350
-30% -$20.8K ﹤0.01% 2007
2016
Q4 		$59K Buy
1,175
+50
+4% +$2.68K ﹤0.01% 1785
2016
Q3 		$68K Sell
1,125
-75
-6% -$4.32K ﹤0.01% 1617
2016
Q2 		$61K Buy
+1,200
New +$51.3K ﹤0.01% 1653
2016
Q1 		– Sell
-200
Closed -$9K – 3801
2015
Q4 		$9K Buy
+200
New +$10.5K ﹤0.01% 2658

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

IFP Advisors's ONCE Position: Q1 2019 in Review

IFP Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 825 shares — an estimated $32K sold.

IFP Advisors first reported a position in ONCE in Q4 2015 and held it in 12 quarters. The position peaked at $192K in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • IFP Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 825 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $32K.
  • IFP Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 12 quarters.
  • IFP Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $192K in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.